Skip to main content
Signal8

Full Access with Signal8 Pro, $49/mo billed annually.

RXO, Inc. (RXO) Form SCHEDULE 13D — Oct 5, 2026

$RXOForm SCHEDULE 13DFiled Oct 5, 2026, 6:42 PM ET0001193125-26-414547Original filing

MFN Partners and affiliates filed a Schedule 13D disclosing beneficial ownership of 32,687,269 RXO shares, or 19.3% of the class, including 4,577,327 warrant shares. On October 4, 2026, RXO entered into a Merger Agreement with C.H. Robinson Worldwide under which RXO will be merged into Parent via a two-step merger structure, and MFN Partners signed a voting and support agreement committing to vote its shares in favor of the deal. Under the Voting Agreement, MFN agreed to transfer restrictions and non-solicitation provisions, though it notes it may engage in merger-arbitrage activity and evaluate alternatives subject to the agreement's terms.

Key figures

Shares Outstanding
164926128
Warrant Shares
4577327
Percent Of Class
19.3%
Acquisition Period
November 1, 2022 through February 12, 2026
Voting Agreement Date
2026-10-04
Beneficially Owned Shares
32687269

AI analysis

Red flags2 · Pro

The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.

    RXO, Inc. (RXO) Form SCHEDULE 13D — Oct 5, 2026: AI Analysis | Signal8